Hypercoagulation States

Causes

• Inherited (Genetic) Thrombophilias:
  • These are caused by mutations in genes that affect blood clotting proteins, making the clotting system overactive or the natural anticoagulant system less effective.
  • Factor V Leiden Mutation: The most common inherited thrombophilia, where Factor V is resistant to inactivation by Protein C.
  • Prothrombin Gene Mutation (Factor II G20210A): Leads to increased production of prothrombin, a key clotting protein.
  • Antithrombin Deficiency: Deficiency of Antithrombin, a natural anticoagulant.
  • Protein C Deficiency: Deficiency of Protein C, which inactivates clotting factors.
  • Protein S Deficiency: Deficiency of Protein S, which assists Protein C.
  • Dysfibrinogenemia: Rare condition where fibrinogen (a clotting protein) is abnormal.
  • High Lipoprotein(a) [Lp(a)]: High levels are an inherited risk factor for both atherosclerosis and thrombosis.
• Acquired Thrombophilias:
  • These develop due to other medical conditions, medications, or lifestyle factors.
  • Antiphospholipid Syndrome (APS): An autoimmune disorder where antibodies (like lupus anticoagulant, anti-cardiolipin, anti-beta2-glycoprotein I) increase clotting risk.
  • Cancer: Malignancy often increases the risk of blood clots, especially in certain types of cancer and with specific treatments.
  • Myeloproliferative Neoplasms (MPN): Blood cancers like polycythemia vera, essential thrombocythemia, and primary myelofibrosis, which involve overproduction of blood cells.
  • Obesity: Increases inflammatory markers and often contributes to other risk factors.
  • Surgery or Trauma: Periods of immobility and tissue injury can activate the clotting system.
  • Prolonged Immobility: (e.g., long flights, bed rest, casts) Slows blood flow, increasing clot risk.
  • Estrogen-Containing Medications: Oral contraceptives, hormone replacement therapy, and selective estrogen receptor modulators (SERMs) increase clotting risk.
  • Pregnancy and Postpartum Period: Hormonal changes and physical compression can increase risk.
  • Inflammatory Bowel Disease (IBD): Chronic inflammation can increase clotting tendency.
  • Nephrotic Syndrome: Kidney disorder leading to protein loss, including natural anticoagulants.
  • Paroxysmal Nocturnal Hemoglobinuria (PNH): A rare blood disorder.
  • Disseminated Intravascular Coagulation (DIC): A complex disorder causing widespread clotting and bleeding.
  • Smoking: Damages blood vessel lining.
  • Dehydration.

Symptoms

• Symptoms of Deep Vein Thrombosis (DVT):
  • Pain or tenderness in the affected limb (most commonly leg or thigh).
  • Swelling (edema) of the affected limb.
  • Redness or discoloration of the skin.
  • Warmth in the affected area.
  • Often, a heavy or aching sensation in the limb.
• Symptoms of Pulmonary Embolism (PE):
  • Sudden shortness of breath (dyspnea).
  • Chest pain (often sharp, worse with deep breath or cough).
  • Rapid heart rate (tachycardia).
  • Coughing (may include bloody mucus).
  • Dizziness or lightheadedness, fainting.
  • Anxiety.
  • These are life-threatening symptoms and require immediate medical attention.
• Symptoms of Arterial Clots:
  • Stroke: Sudden numbness or weakness (often unilateral), speech difficulty (aphasia/dysarthria), confusion, vision changes.
  • Transient Ischemic Attack (TIA - "Mini-stroke"): Temporary stroke-like symptoms that resolve.
  • Heart Attack: Chest pain (angina), shortness of breath, pain radiating to arm/jaw, sweating.
  • Peripheral Arterial Thrombosis: Pain, numbness, coolness, pallor in a limb.
• Other Less Common Clotting Events:
  • Mesenteric Ischemia: Severe abdominal pain due to clots affecting gut blood supply.
  • Cerebral Vein Thrombosis: Severe headache, seizures, neurological deficits.
  • Recurrent Miscarriages: Due to clots in the placenta (a common symptom in antiphospholipid syndrome).

Diagnosis

• Medical History and Physical Exam: The doctor will inquire about personal and family history of blood clots, pregnancy complications, medications, and other medical conditions.
• Blood Tests for Inherited Thrombophilias:
  • Factor V Leiden Mutation: Genetic test for the F5 gene mutation.
  • Prothrombin Gene Mutation: Genetic test for the F2 gene mutation (G20210A).
  • Antithrombin Activity: Measures the level and function of antithrombin.
  • Protein C Activity and Antigen: Measures levels and function.
  • Protein S Activity and Antigen: Measures levels and function.
  • Homocysteine Levels: High levels may indicate a risk (less specific).
  • Lipoprotein(a) [Lp(a)] Levels.
• Blood Tests for Acquired Thrombophilias:
  • Antiphospholipid Antibodies: Lupus anticoagulant, anti-cardiolipin antibodies (IgG, IgM), anti-beta2-glycoprotein I antibodies (IgG, IgM). (Require repeat testing after 12 weeks for confirmation).
  • Tests for Underlying Diseases: Cancer screening, kidney/liver function tests, autoimmune markers, tests for myeloproliferative neoplasms.
• Imaging Tests (if a clot is suspected or present):
  • Duplex Ultrasound: For diagnosing DVT.
  • CT Pulmonary Angiogram (CTPA): For diagnosing PE.
  • CT Scan or MRI: For stroke or other organ clots.

Treatment

• Anticoagulant Medications (Blood Thinners):
  • The cornerstone of treatment for those who have experienced a clot.
  • Heparin (Unfractionated or Low Molecular Weight Heparin - LMWH): Used initially for acute clots, given by injection.
  • Warfarin (Coumadin): An oral anticoagulant used for long-term prevention. Requires regular INR monitoring.
  • Direct Oral Anticoagulants (DOACs): (e.g., rivaroxaban, apixaban, dabigatran, edoxaban) Oral alternatives to warfarin that do not require frequent monitoring. Their use in some specific thrombophilias (e.g., Antiphrombin deficiency, APS) may be limited or require careful consideration.
  • The duration of anticoagulation varies from short-term (e.g., 3-6 months for a provoked DVT) to lifelong (for recurrent clots or high-risk thrombophilias).
• Managing Underlying Causes:
  • Treating cancer, autoimmune diseases, or myeloproliferative neoplasms.
  • Discontinuing or adjusting medications that contribute to hypercoagulability (e.g., estrogen-containing contraceptives).
• Primary Prophylaxis (Prevention in Asymptomatic Individuals):
  • Most asymptomatic individuals with an inherited thrombophilia (e.g., heterozygous Factor V Leiden) do *not* require lifelong anticoagulation.
  • Prophylactic (preventive) anticoagulation may be given during periods of high risk, such as:
    • Major surgery or prolonged hospitalizations.
    • Long-duration travel (e.g., flights >4 hours) with additional risk factors.
    • Pregnancy and postpartum period (often with LMWH injections for high-risk thrombophilias).
  • Low-dose aspirin may be considered for select individuals with high-risk antibody profiles in APS.
• Lifestyle Modifications:
  • Quit smoking.
  • Maintain a healthy weight.
  • Regular physical activity (as advised by a doctor).
  • Stay hydrated.
  • Avoid prolonged immobility; get up and move frequently.

Living With a Clotting Disorder

Most of what matters after a thrombophilia is found is not the diagnosis itself but a handful of decisions: whether anticoagulation continues, which drug, what happens before surgery or a long flight, and which symptoms mean a new clot. These are the practical rules that follow the test result.

When testing helps, and when it does not

Thrombophilia tests are drawn when the answer would change treatment: a clot with no provoking cause in a younger person, clots in unusual sites, repeated pregnancy loss, or a strong family history. They are not drawn during an acute clot or while on a blood thinner, because levels are distorted, and a positive factor V Leiden result in someone whose clot followed surgery usually changes nothing. A high lipoprotein(a) is managed as a heart risk rather than with anticoagulation.

Which blood thinner, and for how long

Apixaban or rivaroxaban is the usual choice for most people and needs no blood monitoring. Warfarin remains the drug for antiphospholipid syndrome, particularly when all three antibodies including the lupus anticoagulant are positive, because the newer drugs allowed more arterial clots in that group. A first deep vein thrombosis or pulmonary embolism with a clear trigger is treated for about three months; an unprovoked clot, or a second one, usually means indefinite treatment reviewed yearly for bleeding risk.

Estrogen, pregnancy, surgery, and travel

Estrogen pills for contraception or menopause are avoided in most people with a known thrombophilia, and progestin-only or non-hormonal options are used instead; our menopause hormone therapy article covers the alternatives. Pregnancy with a high-risk thrombophilia is planned with a hematologist, usually with enoxaparin injections through delivery and six weeks after. Before any operation, the anticoagulant is paused and restarted on a written schedule, never simply stopped. For flights over four hours, walking every hour, calf exercises, hydration, and knee-high compression stockings are standard; our snowbird travel and blood clots guide gives the routine.

What a clot is confused with

A tender cord along a varicose vein is superficial thrombophlebitis, which is less dangerous but can extend into the deep system and is often treated briefly. A pulled calf muscle, a ruptured Baker's cyst behind the knee, and cellulitis all produce a swollen, painful leg; an ultrasound settles it the same day. Breathlessness with pleuritic chest pain in anyone with a thrombophilia is a pulmonary embolism until imaging says otherwise.

Bleeding, and the other risk factors

Black stools, blood in the urine, a nosebleed that will not stop, or a head injury while anticoagulated warrant same-day care. NSAIDs such as ibuprofen roughly double bleeding risk with any blood thinner and are replaced with acetaminophen. Smoking, obesity, and dehydration in the Florida heat add to clotting risk and are the parts within reach. Our hematology team coordinates anticoagulation and specialist referral. The NHLBI and the American Society of Hematology publish patient guidance on clotting disorders.

If you have had a clot and are unsure whether your anticoagulant should continue, or are planning surgery, pregnancy, or hormone therapy, schedule a visit.